Contract facts
Federal4554629206!XOLAIR 150 MG/ML SYRINGEML is a federal award for Dla Troop Support held by Dms Pharmaceutical Group Inc. Estimated value —.
Incumbent footprint
Public recordDms Pharmaceutical Group Inc — $737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SPE2DX21FZ8WS?
SPE2DX21FZ8WS (4554629206!xolair 150 MG ML syringeml) is a Dla Troop Support award with an estimated value of —, currently held by Dms Pharmaceutical Group Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded SPE2DX21FZ8WS?
Dla Troop Support awarded SPE2DX21FZ8WS to Dms Pharmaceutical Group Inc.
Who is the incumbent on SPE2DX21FZ8WS?
Dms Pharmaceutical Group Inc is the incumbent with $737.3M across 100503 related awards in SCOUT’s public footprint.
When does Dms Pharmaceutical Group Inc’s SPE2DX21FZ8WS come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on SPE2DX21FZ8WS — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.